Humacyte

HUMA • NASDAQ • Stock Fundamentals

Humacyte is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Laura E. Niklason, with a market cap of $246.4M.

Market Cap$246.4M

Employees185.0

CEOLaura E. Niklason

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Humacyte

Humacyte (HUMA) has a market capitalization of $246.4M and trades on NASDAQ.

Humacyte has approximately 185 employees.